Contact Us
Quotes News NAV
Market Watch
02 Apr EOD
SENSEX
NIFTY
GOLD
SILVER
CRUDE OIL
 
Market Info EXPAND TICKER
You are here : Corporate Information   |  Company News
Your Result on : Corporate Information | Company News
Date Headline
04-Mar-2026 Eugia Pharma Specialities launches Pomalidomide Capsules in US market
04-Mar-2026 Aurobindo Pharma launches Pomalidomide capsules in US market
28-Feb-2026 Aurobindo Pharma arm receives 4 observations after US FDA inspection
26-Feb-2026 Eugia Pharma Specialities receives USFDA approval for Everolimus Tablets
26-Feb-2026 Aurobindo Pharma gains as arm gets USFDA final nod for Everolimus tablets
26-Feb-2026 Aurobindo Pharma Ltd spurts 1.16%
14-Feb-2026 Aurobindo Pharma consolidated net profit rises 7.62% in the December 2025 quarter
09-Feb-2026 Aurobindo Pharma board considers merger of subsidiaries
09-Feb-2026 Board of Aurobindo Pharma approves PPA with Garuda Renewables
09-Feb-2026 Aurobindo Pharma board appoints directors
<< < 1 2 3 4 5 > >> 
Detailed Quotes
MF Holdings
Company News
Profit and Loss
Quarterly Results
Share Holding Pattern
Deliverable Volumes
Historical Prices
Board of Directors
Director's Report
Peer Comparison
Score Board
Name Change
Financial Ratios
Company Background
Company Snapshot
Balance Sheet
Site Map | Disclaimer | Circular Reports | Research Reports | About Us | Feedback | Careers | Contact Us
Useful Links
Stock : Stock Price Quotes | Stock Market India | Stock Market Global | Corporate Announcement
Market News : Corporate News | Market Commentary | Corporate Results | Economy News | Other Markets | Hot Pursuit | Futures Market
Share Market Updates : BSE Top Gainers - Sensex | NSE Top Gainers - Nifty | BSE Top Losers - Sensex | NSE Top Losers - Nifty | BSE Most Active Scrip by Volume - Sensex |
NSE Most Active Scrip by Volume - Nifty | BSE Most Active Scrip by Value - Sensex | NSE Most Active Scrip by Value - Nifty | Advances and Declinces
Derivatives : Get Quotes | Daily Settlement Prices | Put-Call Ratio | Cost Of Carry
Global Indicator : Stock Market Global | Currency | ADR Prices | FII Investments | Mutual Fund Investments
Services : Equity | Derivatives | Commodities | Mutual Fund | Portfolio Management Services (PMS) | Initial Public Offer (IPO)
Members:
Sebi Regn.No. - BSE : INB010983738 | NSE : INB230983737 | F&O : INF230983737 | NSE Currency: INE230983737 | FMC REGN.MCX : MCX/TCM/CORP/0276 | NCDEX : NCDEX/TCM/CORP/0411
Email ID for redressal of Investor Complaints : investorgrievances@manumangal.com
2012 © MANUBHAI MANGALDAS SECURITIES PVT. LTD All rights reserved Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)